U.S. flag

An official website of the United States government

NM_001114753.3(ENG):c.527del (p.Gln176fs) AND Hereditary hemorrhagic telangiectasia

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 19, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001238767.5

Allele description [Variation Report for NM_001114753.3(ENG):c.527del (p.Gln176fs)]

NM_001114753.3(ENG):c.527del (p.Gln176fs)

Gene:
ENG:endoglin [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
9q34.11
Genomic location:
Preferred name:
NM_001114753.3(ENG):c.527del (p.Gln176fs)
HGVS:
  • NC_000009.12:g.127825857del
  • NG_009551.1:g.33912del
  • NM_000118.4:c.527delA
  • NM_001114753.3:c.527delMANE SELECT
  • NM_001278138.2:c.-20del
  • NM_001406715.1:c.527delA
  • NP_000109.1:p.Gln176Argfs
  • NP_000109.1:p.Gln176fs
  • NP_001108225.1:p.Gln176Argfs
  • NP_001108225.1:p.Gln176fs
  • NP_001393644.1:p.Gln176Argfs
  • LRG_589t1:c.527del
  • LRG_589t2:c.527del
  • LRG_589:g.33912del
  • LRG_589p1:p.Gln176fs
  • LRG_589p2:p.Gln176Argfs
  • NC_000009.11:g.130588136del
  • NM_000118.3:c.527del
  • NM_001114753.2:c.527delA
Protein change:
Q176fs
Links:
dbSNP: rs1830603743
NCBI 1000 Genomes Browser:
rs1830603743
Molecular consequence:
  • NM_001278138.2:c.-20del - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_000118.4:c.527delA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001114753.3:c.527del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001406715.1:c.527delA - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Hereditary hemorrhagic telangiectasia (HHT)
Synonyms:
Osler Weber Rendu syndrome; ORW disease; Osler-Rendu-Weber disease; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0019180; MedGen: C0039445; OMIM: PS187300

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001411596Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Sep 19, 2019)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.

Abdalla SA, Letarte M.

J Med Genet. 2006 Feb;43(2):97-110. Epub 2005 May 6. Review.

PubMed [citation]
PMID:
15879500
PMCID:
PMC2603035

The physiological role of endoglin in the cardiovascular system.

López-Novoa JM, Bernabeu C.

Am J Physiol Heart Circ Physiol. 2010 Oct;299(4):H959-74. doi: 10.1152/ajpheart.01251.2009. Epub 2010 Jul 23. Review.

PubMed [citation]
PMID:
20656886
See all PubMed Citations (4)

Details of each submission

From Invitae, SCV001411596.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in ENG are known to be pathogenic (PMID: 15879500, 20656886, 22385575). This variant has not been reported in the literature in individuals with ENG-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln176Argfs*46) in the ENG gene. It is expected to result in an absent or disrupted protein product.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024